Autoimmune hepatitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 49, Issue 2, 2009, Pages 158-164

  Mieli Vergani, Giorgina ^a   Heller, Solange ^b   Jara, Paloma ^c   Vergani, Diego ^a   Chang, Mei Hwei ^d   Fujisawa, Tomoo ^e   González Peralta, Regino P ^f   Kelly, Deirdre ^g   Mohan, Neelam ^h   Shah, Uzma ⁱ   Murray, Karen F ^j,k,l  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c HOSPITAL INFANTIL LA PAZ   (Spain)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e Eastern Yokohama Hospital   (Japan)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h SIR GANGA RAM HOSPITAL   (India)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j SEATTLE CHILDREN S HOSPITAL   (United States)

^k Department of Pediatrics ^*

^l Hepatobiliary Program   (United States)

more..

Author keywords

Autoimmune hepatitis; Hepatitis; Immunosuppression; Liver disease; Pediatrics

Indexed keywords

6 METHYLTHIOINOSINE; AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BUDESONIDE; CYCLOSPORIN A; IMMUNOGLOBULIN G; LIVER ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SMOOTH MUSCLE ANTIBODY; TACROLIMUS; THIOPURINE METHYLTRANSFERASE; TIOGUANINE; URSODEOXYCHOLIC ACID;

AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; AUTOIMMUNE HEPATITIS; B LYMPHOCYTE; BRAIN DISEASE; CELL PROLIFERATION; CHOLANGIOGRAPHY; CLINICAL ASSESSMENT; DIAGNOSTIC PROCEDURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIZZINESS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG METABOLISM; DRUG WITHDRAWAL; ENTERITIS; GRAFT DYSFUNCTION; HAIR LOSS; HEADACHE; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TOXICITY; LIVER TRANSPLANTATION; LONG TERM CARE; NAUSEA; NEUTROPENIA; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; SCLEROSING CHOLANGITIS; SEX RATIO; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; CHILD; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; PREDNISOLONE;

EID: 68949151581     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181a1c265     Document Type: Review

References (43)

1. Vergani D, Mieli-Vergani G. Autoimmune hepatitis. In: Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd ed. Chichester, UK: Blackwell Publishing; 2007. pp. 1089-1101.
2. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/ sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001;33:544-553
3. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-547
4. Ahonen P, Myllarniemi S, Sipila I, et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322:1829-1836
5. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
6. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938
7. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-176
8. Vergani D, Alvarez F, Bianchi FB, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-683
9. Gregorio GV, Jones HW, Choudhuri K, et al. Autoantibody prevalence in chronic hepatitis B virus infection: effect of alpha interferon. Hepatology 1996;24:520-523
10. Gregorio GV, Pensati P, Iorio R, et al. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus infection. Clin Exp Immunol 1998;112:471-476
11. Dhawan A, Taylor RM, Cheeseman P, et al. Wilson disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 2005;11:441-448
12. Cotler SJ, Kanji K, Keshavarzian A, et al. Prevalence and significance of autoantibodies in patients with non-alcoholic steato-hepatitis. J Clin Gastroenterol 2004;38:5801-5804
13. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997;40: 1601-1611
14. Hilário MO, Len CA, Roja SC, et al. Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr 2004; 43:637-642
15. Muratori P, Muratori L, Agostinelli D, et al. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity 2002; 35:497-500.
16. Lapierre P, Hajoui O, Homberg JC, et al. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 1999; 116:643-649
17. Manns M, Gerken G, Kyriatsoulis A, et al. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987;1:292-294
18. Ma Y, Okamoto M, Thomas MG, et al. Antibodies to conforma-tional epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002;35:658-664
19. Costa M, Rodriguez-Sanchez JL, Czaja AJ, et al. Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis. Clin Exp Immunol 2000; 121:364-374
20. Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 2000; 355:1510-1515
21. Gassert DJ, Garcia H, Tanaka K, et al. Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis. Dig Dis Sci 2007;52:2433-2437
22. Ferreira AR, Roquete ML, Toppa NH, et al. Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2008;46:65-70.
23. Sogo T, Fujisawa T, Inui A, et al. Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis. Hepatol Res 2006;34:187-192
24. Al-Chalabi T, Heneghan MA. Remission in autoimmune hepatitis: what is it, and can it ever be achieved? Am J Gastroenterol 2007;102:1013-1015
25. Kerkar N, Annunziato RA, Foley L, et al. Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr 2006;43:629-634
26. Samaroo B, Samyn M, Buchanan C, et al. Long-term daily oral treatment with prednisolone in children with autoimmune liver disease does not affect final adult height. Hepatology 2006;44:438A.
27. Alvarez F. Autoimmune hepatitis and primary sclerosing cholan-gitis. Clin Liver Dis 2006;10:89-107. vi.
28. Chang MH, Hadzic D, Rouassant SH, et al. Acute and chronic hepatitis: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004;39(Suppl 2):S584-8.
29. Saadah OI, Smith AL, Hardikar W. Long-term outcome of autoimmune hepatitis in children. J Gastroenterol Hepatol 2001;16: 1297-1302
30. Ferreira AR, Roquete ML, Penna FJ, et al. Type 1 autoimmune hepatitis in children and adolescents: assessment of immunosup-pressive treatment withdrawal. J Pediatr (Rio J) 2005;81:343-348
31. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children. Clin Liver Dis 2002;6:335-346
32. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-497
33. Czaja AJ, Menon KV, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology 2002;35:890-897
34. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54-66.
35. Rumbo C, Emerick KM, Emre S, et al. Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report. J Pediatr Gastroenterol Nutr 2002; 35:391-398
36. Alvarez F, Ciocca M, Canero-Velasco C, et al. Short-term cyclos-porine induces a remission of autoimmune hepatitis in children. J Hepatol 1999;30:222-227
37. Cuarterolo M, Ciocca M, Velasco CC, et al. Follow-up of children with autoimmune hepatitis treated with cyclosporine. J Pediatr Gastroenterol Nutr 2006;43:635-639
38. Mieli-Vergani G, Bargiota K, Samyn M, Vergani D. Therapeutic aspects of autoimmune liver disease in children. In: Dienes HP, Leuschner U, Lohse AW, Manns MP (eds). Autoimmune Liver Diseases-Falk Symposium. Dordrecht, The Netherlands: Springer; 2005. pp. 278-282
39. Mitchell SA, Bansi DS, Hunt N, et al. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001;121:900-907
40. Gregorio GV, McFarlane B, Bracken P, et al. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity 2002;35:515-519
41. Duclos-Vallee JC, Sebagh M, Rifai K, et al. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histologi-cal recurrence precedes clinical and biochemical recurrence. Gut 2003;52:893-897
42. Kerkar N, Hadzic N, Davies ET, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409-413
43. Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004;40:3-7.